These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17118849)

  • 21. Concurrent chemoradiotherapy for esophageal cancer with malignant fistula.
    Koike R; Nishimura Y; Nakamatsu K; Kanamori S; Shibata T
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1418-22. PubMed ID: 18234437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
    J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective trial of radiotherapy for patients 80 years of age or older with squamous cell carcinoma of the thoracic esophagus.
    Kawashima M; Kagami Y; Toita T; Uno T; Sugiyama M; Tamura Y; Hirota S; Fuwa N; Hashimoto M; Yoshida H; Shikama N; Kataoka M; Akuta K; Sasaki K; Tamamoto T; Nemoto K; Ito H; Kato H; Yamada S; Ikeda H
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1112-21. PubMed ID: 16376491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation therapy for esophageal cancer in Japan: results of the Patterns of Care Study 1999-2001.
    Kenjo M; Uno T; Murakami Y; Nagata Y; Oguchi M; Saito S; Numasaki H; Teshima T; Mitsumori M
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):357-63. PubMed ID: 19735863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma.
    Morota M; Gomi K; Kozuka T; Chin K; Matsuura M; Oguchi M; Ito H; Yamashita T
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):122-8. PubMed ID: 19327900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
    Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
    Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment outcome and prognostic factors in non-metastatic esophageal carcinoma.
    Saglam EK; Kilciksiz S; Ozseker N; Karadeniz A; Oral EN; Kizir A
    Saudi Med J; 2007 Jul; 28(7):1086-90. PubMed ID: 17603717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
    Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S
    Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
    Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus.
    Javeri H; Arora R; Correa AM; Hofstetter WL; Lee JH; Liao Z; McAleer MF; Maru D; Bhutani MS; Swisher SG; Izzo JG; Ajani JA
    Cancer; 2008 Sep; 113(6):1302-8. PubMed ID: 18623381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective comparison of clinical outcomes and quality of life measures between definitive chemoradiation alone and radical surgery for clinical stage II-III esophageal carcinoma.
    Yamashita H; Okuma K; Seto Y; Mori K; Kobayashi S; Wakui R; Ohtomo K; Nakagawa K
    J Surg Oncol; 2009 Nov; 100(6):435-41. PubMed ID: 19653240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accelerated radical radiotherapy for non-small cell lung cancer using two common regimens: a single-centre retrospective study of outcome.
    Pemberton LS; Din OS; Fisher PM; Hatton MQ
    Clin Oncol (R Coll Radiol); 2009 Apr; 21(3):161-7. PubMed ID: 19111452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.
    Grigiene R; Valuckas KP; Aleknavicius E; Kurtinaitis J; Letautiene SR
    BMC Cancer; 2007 Dec; 7():234. PubMed ID: 18154683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer.
    Nakajima TE; Ura T; Ito Y; Kato K; Minashi K; Nihei K; Hironaka S; Boku N; Kagami Y; Muro K
    Jpn J Clin Oncol; 2009 Jan; 39(1):37-42. PubMed ID: 19103671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: the impact of clinical heterogeneity.
    Adelstein DJ; Rice TW; Rybicki LA; Saxton JP; Videtic GM; Murthy SC; Zuccaro G; Vargo JJ; Dumot JA; Carroll MA
    Am J Clin Oncol; 2007 Apr; 30(2):172-80. PubMed ID: 17414467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for severe Dysphagia after concurrent chemoradiotherapy for head and neck cancers.
    Koiwai K; Shikama N; Sasaki S; Shinoda A; Kadoya M
    Jpn J Clin Oncol; 2009 Jul; 39(7):413-7. PubMed ID: 19383615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma.
    Nishio S; Katsumata N; Matsumoto K; Tanabe H; Yonemori K; Kohno T; Shimizu C; Ando M; Kasamatsu T; Fujiwara Y
    Oncol Rep; 2008 Feb; 19(2):497-503. PubMed ID: 18202800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
    Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
    Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
    Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical analysis of 33 cases of primary esophageal small cell carcinoma].
    Duan HB; Wu HY; Su XD; Zeng CG; Dai WQ; Huang L
    Ai Zheng; 2007 Jul; 26(7):771-4. PubMed ID: 17626757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.